Vapotherm, Inc. (VAPO)
USD 2.17
(-0.46%)
USD 2.17
(-0.46%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -9.64 USD | 71.56% |
| 2022 | -33.89 USD | -83.39% |
| 2021 | -18.48 USD | 2.12% |
| 2020 | -18.88 USD | 14.03% |
| 2019 | -21.96 USD | 81.22% |
| 2018 | -116.95 USD | 67.25% |
| 2017 | -357.12 USD | 9.58% |
| 2016 | -394.95 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -2.22 USD | 3.9% |
| 2024 Q1 | -2.31 USD | -36.69% |
| 2023 Q4 | -1.69 USD | 28.99% |
| 2023 Q2 | -2.34 USD | 34.27% |
| 2023 Q1 | -3.56 USD | 43.58% |
| 2023 Q3 | -2.38 USD | -1.71% |
| 2023 FY | - USD | 71.56% |
| 2022 Q4 | -6.31 USD | 19.62% |
| 2022 Q1 | -6.97 USD | -21.22% |
| 2022 FY | - USD | -83.39% |
| 2022 Q2 | -12.85 USD | -84.36% |
| 2022 Q3 | -7.85 USD | 38.91% |
| 2021 FY | - USD | 2.12% |
| 2021 Q3 | -4.18 USD | 21.72% |
| 2021 Q2 | -5.34 USD | -65.33% |
| 2021 Q1 | -3.23 USD | 39.63% |
| 2021 Q4 | -5.75 USD | -37.56% |
| 2020 FY | - USD | 14.03% |
| 2020 Q4 | -5.35 USD | -37.53% |
| 2020 Q1 | -5.30 USD | -10.88% |
| 2020 Q3 | -3.89 USD | -39.93% |
| 2020 Q2 | -2.78 USD | 47.55% |
| 2019 Q1 | -6.12 USD | 45.16% |
| 2019 Q4 | -4.78 USD | 8.6% |
| 2019 Q3 | -5.23 USD | 13.41% |
| 2019 Q2 | -6.04 USD | 1.31% |
| 2019 FY | - USD | 81.22% |
| 2018 Q2 | -107.11 USD | -18.18% |
| 2018 FY | - USD | 67.25% |
| 2018 Q4 | -11.16 USD | 87.09% |
| 2018 Q1 | -90.63 USD | 7.21% |
| 2018 Q3 | -86.44 USD | 19.3% |
| 2017 Q3 | -90.20 USD | -0.67% |
| 2017 Q4 | -97.67 USD | -8.28% |
| 2017 FY | - USD | 9.58% |
| 2017 Q1 | -87.10 USD | 0.0% |
| 2017 Q2 | -89.60 USD | -2.87% |
| 2016 FY | - USD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Abbott Laboratories | 3.30 USD | 392.121% |
| Allurion Technologies Inc. | -2.31 USD | -317.316% |
| Artivion, Inc. | -0.75 USD | -1185.333% |
| Avanos Medical, Inc. | -1.33 USD | -624.812% |
| Butterfly Network, Inc. | -0.65 USD | -1383.077% |
| Butterfly Network, Inc. | -0.65 USD | -1383.077% |
| Bio-Rad Laboratories, Inc. | -21.82 USD | 55.82% |
| Boston Scientific Corporation | 1.08 USD | 992.593% |
| Perspective Therapeutics, Inc. | -0.10 USD | -9540.0% |
| CONMED Corporation | 2.10 USD | 559.048% |
| Edwards Lifesciences Corporation | 2.31 USD | 517.316% |
| Paragon 28, Inc. | -0.58 USD | -1562.069% |
| Glaukos Corporation | -2.78 USD | -246.763% |
| Globus Medical, Inc. | 1.09 USD | 984.404% |
| Inspire Medical Systems, Inc. | -0.72 USD | -1238.889% |
| Integer Holdings Corporation | 2.72 USD | 454.412% |
| Medtronic plc | 2.77 USD | 448.014% |
| Nevro Corp. | -2.56 USD | -276.563% |
| Owlet, Inc. | -4.53 USD | -112.804% |
| Penumbra, Inc. | 2.37 USD | 506.751% |
| Vicarious Surgical Inc. | -0.49 USD | -1867.347% |
| Smith & Nephew plc | 0.60 USD | 1706.667% |
| Sonendo, Inc. | -0.65 USD | -1383.077% |
| STERIS plc | 3.83 USD | 351.697% |
| Stryker Corporation | 8.34 USD | 215.588% |
| Zimmer Biomet Holdings, Inc. | 4.91 USD | 296.334% |